Sign in
4

Changes in Ownership

International Stem Cell CORP Filed Acc 0001019687-14-004207

Options or other derivatives

  • Executive Vice President acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Craw John Simon · Executive Vice President

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-11-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,000 $0.11 2024-11-10 60,000 60,000 D
Loading xslF345X03/isco_f4-craw.xml…